Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antiviral Research

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ANTIVIRAL.2006.08.003PMID 17014915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.

  2005cited by this paper
• Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs.

  2005cited by this paper
• The search for effective HIV vaccines.

  2005cited by this paper
• Cell mediated and antibody immune response to inactivated hepatitis A vaccine.

  2005cited by this paper
• IgA-coated particles of Hepatitis A virus are translocalized antivectorially from the apical to the basolateral site of polarized epithelial cells via the polymeric immunoglobulin receptor.

  2005cited by this paper
• Replication and in vivo repair of the hepatitis A virus genome lacking the poly(A) tail.

  2005cited by this paper
• A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

  2004cited by this paper
• Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.

  2004cited by this paper
• Homogeneous hepatitis A virus particles. Proteolytic release of the assembly signal 2A from procapsids by factor Xa.

  2003cited by this paper
• Rectal immunization of mice with hepatitis A vaccine induces stronger systemic and local immune responses than parenteral immunization.

  2003cited by this paper
• Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion.

  2003cited by this paper
• Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use

  2002cited by this paper
• Relative infectivity of hepatitis A virus by the oral and intravenous routes in 2 species of nonhuman primates.

  2002cited by this paper
• Analysis of Deletion Mutants Indicates that the 2A Polypeptide of Hepatitis A Virus Participates in Virion Morphogenesis

  2002cited by this paper
• Antigenic Properties of the Human Immunodeficiency Virus Transmembrane Glycoprotein during Cell-Cell Fusion

  2002cited by this paper
• Identification of VP1/2A and 2C as Virulence Genes of Hepatitis A Virus and Demonstration of Genetic Instability of 2C

  2002cited by this paper
• Chimeric hepatitis A virus particles presenting a foreign epitope (HIV gp41) at their surface.

  2002cited by this paper
• How Pathogenic Viruses Work

  2002cited by this paper
• Chimeric Plant Virus Particles as Immunogens for Inducing Murine and Human Immune Responses against Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Detection of antibodies to HAV 3C proteinase in experimentally infected chimpanzees and in naturally infected children.

  2001cited by this paper
• Experimental hepatitis A virus infection in guinea pigs

  2001cited by this paper
• H2 strain attenuated live hepatitis A vaccines:protective efficacy in a hepatitis A outbreak.

  2000cited by this paper
• Hepatitis A Virus-Specific Immunoglobulin A Mediates Infection of Hepatocytes with Hepatitis A Virus via the Asialoglycoprotein Receptor

  2000cited by this paper
• Intrinsic Signals for the Assembly of Hepatitis A Virus Particles

  1999cited by this paper
• Improving Proteolytic Cleavage at the 3A/3B Site of the Hepatitis A Virus Polyprotein Impairs Processing and Particle Formation, and the Impairment Can Be Complemented intrans by 3AB and 3ABC

  1999cited by this paper
• A rational basis for mucosal vaccination against HIV infection

  1999cited by this paper
• Antigenic epitopes of the hepatitis A virus polyprotein.

  1999cited by this paper
• Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus.

  1997cited by this paper
• Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.

  1997cited by this paper
• Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

  1996cited by this paper
• [15] Nonisotopic assays of viral polymerases and related proteins

  1996cited by this paper
• Nonisotopic assays of viral polymerases and related proteins.

  1996cited by this paper
• Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells

  1996cited by this paper
• Evagination of Taenia solium in the fourth ventricle.

  1996cited by this paper
• Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets

  1995cited by this paper
• Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus)

  1995cited by this paper
• Hepatitis B virus core particles as epitope carriers.

  1995cited by this paper
• A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1

  1994cited by this paper
• Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS

  1994cited by this paper
• Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells

  1993cited by this paper
• Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.

  1993cited by this paper
• Expression and characterization of recombinant hepatitis A virus 3C proteinase.

  1992cited by this paper
• Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection.

  1992cited by this paper
• Vaccination against hepatitis A: comparison of different short-term immunization schedules.

  1992cited by this paper
• A new method for measuring reverse transcriptase activity by ELISA.

  1992cited by this paper
• Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles

  1990cited by this paper
• Immunoreactivity of human and rabbit antisera to hepatitis A virus

  1988cited by this paper
• Van Damme A.

  1986cited by this paper
• Detection and persistence of specific iga antibodies in serum of patients with hepatitis A by capture radioimmunoassay

  1983cited by this paper
• Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay

  1977cited by this paper

• Artificial polyepitope HIV-1 immunogen containing mimotope of 2F5 epitope.

  2016cites this paper
• Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.

  2015cites this paper
• Design and evaluation of immunogens based on gp41 membrane-proximal external region for development of a vaccine against human immunodeficiency virus type 1

  2015cites this paper
• Elicits Neutralizing Antibodies to HIV-1 A Fusion Intermediate gp 41 Immunogen Microbiology

  2014cites this paper
• A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1*

  2014cites this paper
• Development of prophylactic vaccines against HIV-1

  2013cites this paper
• Construction, expression and immunogenicity of a novel anti-hypertension angiotensin II vaccine based on hepatitis A virus-like particle

  2013cites this paper
• Expression and immunological characterization of cardamom mosaic virus coat protein displaying HIV gp41 epitopes

  2013cites this paper
• Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design.

  2012cites this paper
• B cell responses against the HIV-1 envelope glycoproteins

  2012cites this paper
• A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin

  2012cites this paper
• Novel Immunogens based on the gp41 protein of Human Immunodeficiency Virus type 1 and Display Systems for their Affinity Maturation

  2011cites this paper
• Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant

  2011cites this paper
• Association of variations of NAb 2F5 and 4E10 epitopes and disease progression in Chinese antiretroviral treatment-naïve patients infected with HIV-1 clade B'.

  2010cites this paper
• Hepatitis A virus (HAV) packaging size limit

  2009cites this paper
• Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope

  2009cites this paper
• The unique role of domain 2A of the hepatitis A virus precursor polypeptide P1-2A in viral morphogenesis.

  2008cites this paper
• Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

  2008cites this paper
• The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design

  2008cites this paper
• Antigenicity and immunogenicity of the membrane proximal external region of the HIV-1 envelope protein gp41

  2007cites this paper
• Avaliação da susceptibilidade de Cavia Porcellus ao vírus da Hepatite A

  2007cites this paper
• Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein.

  2007cites this paper
• Immunogenic epitopes on the surface of the hepatitis A virus capsid: Impact of secondary structure and/or isoelectric point on chimeric virus assembly.

  2007cites this paper
• In Vitro Synergy between Peptides or Neutralizing Antibodies Targeting the N-and C-Terminal Heptad Repeats of HIV Type 1 gp41

  year unknowncites this paper